← Back to Search

Advanced Endoscopic Imaging for Gastric Cancer

N/A
Recruiting
Led By Shai Friedland
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must be at least 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial is looking for new ways to find cancer in the stomach and intestines.

Who is the study for?
This trial is for adults (18+) who are scheduled for an endoscopy. It's open to all genders and ethnicities, as long as they don't have unstable vital signs or participation in another study that conflicts with this one.Check my eligibility
What is being tested?
The trial is testing new imaging technologies like wide field fluorescence system, CellVizio, indocyanine green, Dual axis endoscopic microscope, fluorescein, and fluorescent peptide to detect malignant conditions in the gastrointestinal tract.See study design
What are the potential side effects?
Potential side effects may include reactions to the fluorescent substances used such as indocyanine green or fluorescein (like allergic reactions), discomfort from the advanced imaging equipment, and typical risks associated with endoscopies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Detection of neoplasia

Trial Design

1Treatment groups
Experimental Treatment
Group I: endoscopy armExperimental Treatment6 Interventions
imaging performed in conjunction with the regularly scheduled endoscopy during which the newer imaging techniques will be used to detect premalignant conditions. includes wide field fluorescence, microscopy, Raman spectroscopy and/or ultrasound.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
indocyanine green
2013
Completed Phase 3
~240

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,926,841 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,685 Previous Clinical Trials
6,930,458 Total Patients Enrolled
Stanford UniversityLead Sponsor
2,378 Previous Clinical Trials
17,332,863 Total Patients Enrolled

Media Library

Dual axis endoscopic microscope Clinical Trial Eligibility Overview. Trial Name: NCT01034670 — N/A
Gastrointestinal Disease Research Study Groups: endoscopy arm
Gastrointestinal Disease Clinical Trial 2023: Dual axis endoscopic microscope Highlights & Side Effects. Trial Name: NCT01034670 — N/A
Dual axis endoscopic microscope 2023 Treatment Timeline for Medical Study. Trial Name: NCT01034670 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are taking part in this research project?

"Indeed. On clinicaltrials.gov, the information indicates that this research is recruiting participants as of now. It was first posted on June 1st 2009 and most recently edited on May 11th 2022; with a goal of 500 patients being recruited from one site."

Answered by AI

Is enrollment for this research project still being accepted?

"Affirmative. According to the data on clinicaltrials.gov, this medical trial is still recruiting patients since it was first shared in June 2009 and updated most recently in May 2022. The study seeks 500 participants from a single site."

Answered by AI

What are the main maladies that Dual axis endoscopic microscope is typically employed to treat?

"Dual axis endoscopic microscope is a viable form of treatment for pneumocystis jirovecii pneumonia, genus pneumocystis, and the evaluation of hepatic function."

Answered by AI
~22 spots leftby Dec 2024